Bloom Science has raised seed money and licensed technology to treat CNS diseases via the gut-brain axis. Building on research into the ketogenic diet, Bloom is initially focusing on developing bacterial treatments for epilepsy.
Takeda Pharmaceutical Company Limited announced a strategic collaboration with NuBiyota LLC for the development of Microbial Ecosystem Therapeutic products.